CHICAGO, Sept. 5, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Google (Nasdaq:GOOGL-Free Report), AbbVie (NYSE:ABBV-Free Report), Abbott Laboratories (NYSE:ABT-Free Report), Apple Inc. (Nasdaq:AAPL-Free Report) and Intel (Nasdaq:INTC-Free Report).
http://photos.prnewswire.com/prnvar/20101027/ZIRLOGO
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Thursday's Analyst Blog:
Google's Calico in $500M JV with AbbVie
Calico, Google's (Nasdaq:GOOGL-Free Report) year-old health startup is collaborating with biotechnology drugmaker, AbbVie (NYSE:ABBV-Free Report), a spin-off from Abbott Laboratories (NYSE:ABT-Free Report), for a joint venture to formulate treatments for cancer and Alzheimer's. The project will be worth $500 million.
Google Inc. and AbbVie Inc. are to invest $250 million each. Besides this, another $1 billion may be invested in the project, if required. The entire expenses along with the profits earned by the venture will be shared by both the companies.
During the first five years of the collaboration, Calico will be looking after research and initial development, which will include construction of a world-class facility in the San Francisco Bay Area. In the second phase, AbbVie will be given the choice to take up management and marketing of projects that are ready.
AbbVie will use its pharmaceutical prowess to support Calico in scientific as well as clinical development and will use its commercial competence to make sure that these therapies are brought to the market.
Since Calico is headed by Arthur Levinson, chairman of Apple Inc. (Nasdaq:AAPL-Free Report), there are speculations that Google's the entry into healthcare could include a new wearable Apple device.
Such alliances are not uncommon. Intel (Nasdaq:INTC-Free Report) and GE together formed Care Innovations in 2011. The joint venture focuses on technology solutions to connect people to their care teams and the ability to live without being dependent on anyone.
Google currently holds a Zacks Rank #3 (Hold).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on GOOGL - FREE
Get the full Report on ABBV - FREE
Get the full Report on ABT - FREE
Get the full Report on AAPL - FREE
Get the full Report on INTC - FREE
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO
SOURCE Zacks Investment Research, Inc.
